N
NovaBay Pharmaceuticals Inc
AMEX:SDEV
NovaBay Pharmaceuticals Inc
AMEX:SDEV
Price:
1.22
USD
2.52%
Market Closed
Market Cap:
$33.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
NovaBay Pharmaceuticals Inc
AMEX:SDEV
|
US |
|
P
|
Parker-Hannifin Corp
F:PAR
|
US |
|
G
|
Gold Fields Ltd
DUS:EDGA
|
ZA |
|
A
|
Advanced Micro Devices Inc
XMUN:AMD
|
US |
|
D
|
Darden Restaurants Inc
XMUN:DDN
|
US |
|
B
|
Basf Se
BET:BASF
|
DE |
|
K
|
KeyCorp
F:KEY
|
US |
|
R
|
Race Oncology Ltd
OTC:RAONF
|
AU |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SDEV's stock price target?
Not Available
SDEV does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for NovaBay Pharmaceuticals Inc?
Projected CAGR
29%
29%
Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 2 years is 29%.
What is the Gross Profit forecast for NovaBay Pharmaceuticals Inc?
Projected CAGR
26%
26%
The compound annual growth rate for Gross Profit over the next 1 year is 26%.
